Remove Clinical Trials Remove Information Remove Sleep
article thumbnail

Tryp Therapeutics Announces Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan

Cannabis Law Report

The study is expected to be the world’s first Phase 2a clinical trial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinical trial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.

article thumbnail

Could CBN really help you sleep? Consumer study data suggest yes.

The Cannigma

CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. It also, allegedly, helps with sleep (more on that below). Back to our study.

Sleep 137
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Trouble Sleeping: Cannabis for Insomnia Relief

MMJ Recs

Many patients are turning to cannabis for insomnia relief, seeking its potential to improve sleep quality and duration. Insomnia is a common sleep disorder characterized by difficulty falling asleep, staying asleep, or experiencing non-restorative sleep despite having the opportunity to sleep.

Sleep 111
article thumbnail

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Cannabis Law Report

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.

article thumbnail

Getting to Know Cannabigerol with Bonni Goldstein, MD

Project CBD

And it does appear to address some of the main issues that people turn to cannabis for — inflammation, pain, anxiety, sleep problems, depression, and cancer. It was highly rated for anxiety, pain, depression, and sleep problems. But we may be on the cusp of having those trials, which would be very exciting.

article thumbnail

What is CBN (Cannabinol)? How does the natural byproduct of THC work?

The Cannigma

Of course, this plant is now known to be marijuana (or Type I cannabis), which is still commonly used for sleep and analgesia today. CBN has been receiving a lot of attention for its ability to induce sleep, as it’s frequently marketed as nature’s sleep aid. What can the current clinical trials tell us?

THC 140
article thumbnail

Why more Parkinson’s patients don’t use cannabis

The Cannigma

Taken together, the lack of guidance and lack of information about what treatments patients are taking, may underlie “inconsistencies in both use and reported effectiveness,” the researchers stated. Where do Parkinson’s patients get information about cannabis? Here are the most interesting statistics from the survey. Of the 43.9%

Patients 145